Celecoxib and Trastuzumab in Treating Women With Metastatic Breast Cancer

PHASE2CompletedINTERVENTIONAL

Timeline

Start Date

June 30, 2000

Study Completion Date

February 29, 2004

Conditions

Breast Cancer

Interventions

BIOLOGICAL

trastuzumab

DRUG

celecoxib

Trial Locations (1)

Memorial Sloan-Kettering Cancer Center, New York

All Listed Sponsors

collaborator

National Cancer Institute (NCI)

NIH

lead

Memorial Sloan Kettering Cancer Center

OTHER

NCT00006381 - Celecoxib and Trastuzumab in Treating Women With Metastatic Breast Cancer | Biotech Hunter | Biotech Hunter